Baseline clinical features of study eyes
| M0 (N=1312) | M1A (N=373) | M1S (N=651) | Overall (N=2336) | |
| Baseline VA | ||||
| Mean (SD) | 68.3 (21.2) | 61.9 (19.7) | 64.6 (22.3) | 66.2 (21.4) |
| Median (min, max) | 76.0 (0, 94.0) | 70.0 (0, 89.0) | 70.0 (0, 94.0) | 76.0 (0, 94.0) |
| Baseline VA by category | ||||
| ≥70 | 931 (71.0%) | 188 (50.4%) | 404 (62.1%) | 1523 (65.2%) |
| 51–69 | 190 (14.5%) | 107 (28.7%) | 114 (17.5%) | 411 (17.6%) |
| 36–50 | 73 (5.6%) | 35 (9.4%) | 50 (7.7%) | 158 (6.8%) |
| ≤35 | 118 (9.0%) | 43 (11.5%) | 83 (12.7%) | 244 (10.4%) |
| Lens status | ||||
| Phakic | 1176 (89.6%) | 318 (85.3%) | 567 (87.1%) | 2061 (88.2%) |
| Pseudophakic | 136 (10.4%) | 55 (14.7%) | 84 (12.9%) | 275 (11.8%) |
| Previous vitrectomy | ||||
| No | 1201 (91.5%) | 332 (89.0%) | 604 (92.8%) | 2137 (91.5%) |
| Yes | 111 (8.5%) | 41 (11.0%) | 47 (7.2%) | 199 (8.5%) |
| Previous DME | ||||
| No | 1266 (96.5%) | 263 (70.5%) | 582 (89.4%) | 2111 (90.4%) |
| Yes | 46 (3.5%) | 110 (29.5%) | 69 (10.6%) | 225 (9.6%) |
Baseline (first recording of stable proliferative diabetes following panretinal photocoagulation) visual acuity (VA) in Early Treatment Diabetic Retinopathy Study letters shown for overall cohort and substratified by macular status. Mean, median, SD, minimum and maximum values shown. Lens status, as well as, history of vitrectomy or diabetic macular oedema is also shown.
DME, diabetic macular oedema .